A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis

Clinical trial NCT00876447 · COMPLETED

Trial details

NCT number: NCT00876447
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Overactive Bladder

Start date: 2009-01-01
Primary completion: 2013-06-12
Enrollment: 397

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.